Placeholder

View on Med Ed: The Devil is in the Details

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 1787. Category: .

Product Description

It has been a year since Pfizer rocked the CME sector by announcing it would no longer fund physician CME programs provided by third-party medical education and communications companies. Other major pharma companies quickly followed with pledges to either end third-party funding or to disclose when third-party funding was used in their CME activities. On the provider side, communications companies have spun off their medical education units in an effort to establish a clear boundary between their promotional businesses and their CME operations.
These moves were prompted mainly as a result of revised guidelines issued by the Accreditation Council for Continuing Medical Education (ACCME) calling for more stringent monitoring and disclosure of commercial…

Sidebar:
ViewPoint
Selected Responses to the ACCME’s Proposed “Commercial Support-Free” Designation

Thought Leaders
Mary Manna Anderson. President, HLS, CommonHealth’s founding medical education unit, excels in the development and dissemination of scientific messages by employing new market approaches to connect the insights of opinion leaders with the clinical realities of practicing physicians. For more information, visit commonhealth.com/hls.
Mark Bard. President, Manhattan Research, a Decision Resources Inc. company that offers market research and advisory services focused on the digital trends shaping the future of consumer and physician marketing. For more information, visit manhattanresearch.com.
Chris Bogan. CEO, Best Practices LLC, a research, consulting, database, and publishing firm focused on the pharmaceutical, biotech, medical device, and healthcare industries. For more information, visit best-in-class.com.
Sandra J.P. Dennis. Deputy General Counsel for Healthcare, Biotechnology Industry Organization (BIO), which provides advocacy, business development, and communications services for more than 1,200 biotechnology members worldwide. For more information, visit bio.org.
Ezra Ernst. General Manager, Medscape LLC, an accredited provider of continuing medical education. For more information, visit medscapecme.com.
Murray Kopelow, M.D. Chief Executive, the Accreditation Council for Continuing Medical Education (ACCME), a nonprofit group focused on the identification, development, and promotion of standards for quality continuing medical education used by physicians. For more information, visit accme.org.
Jack Lewin, M.D. CEO, American College of Cardiology, a nonprofit medical society that leads the formulation of health policy, standards, and guidelines; supports cardiovascular research; and provides professional education programs. For more information, visit acc.org.
Karen Sullivan. Editor/Writer, ProCom, part of CommonHealth, which creates and delivers unique domestic and global educational programs across multiple channels that maximize participation and retention. For more information, visit commonhealth.com/procom.
Jeffrey Uppington, M.B.B.S. Director, District 8, California Society of Anesthesiologists, a physician organization dedicated to promoting the highest professional standards in anesthesiology, to fostering excellence through continuing medical education, and to serving as an advocate for anesthesiologists and their patients. For more information, visit csahq.org.
Michael Zilligen. General Manager, ProCom, a part of CommonHealth, that creates and delivers unique domestic and global educational programs across multiple channels that maximize participation and retention. For more information, visit commonhealth.com/procom.

FEEDBACK